Extraordinary General Meeting 2018

Notice of Extraordinary General Meeting in Sprint Bioscience AB (publ)

The shareholders of Sprint Bioscience AB (publ), reg. no. 556789-7557, are hereby invited to the Extraordinary General Meeting on Tuesday 6 February 2018 at 13.00 at Redeye's office, Mäster Samuelsgatan 42, Stockholm.

Right to participate in the General Meeting

Shareholders who wish to attend the General Meeting shall in part be entered in the share register maintained by Euroclear Sweden AB on Wednesday 31 January 2018, in part register with the company by Wednesday 31 January 2018.

Notification shall be made by letter to Sprint Bioscience AB (publ), Attn: Sara Ellemar, Novum, Hälsovägen 7, 141 57 Huddinge, by telephone to Sara Ellemar on telephone number +46 8 411 44 55, or by e-mail to info@sprintbioscience.com. The notification must include name, personal/corporate identity number, shareholding, address, daytime telephone number and details of any advisors (maximum two) and, where applicable, details of proxies.

Ombudsmen

Shareholders represented by proxy must issue a dated power of attorney for the proxy. If the power of attorney is issued by a legal entity, a certified copy of the certificate of registration or equivalent for the legal entity must be attached. The power of attorney and any certificate of registration may not be older than one year, although the power of attorney may be older if it is valid for a longer period of time, up to a maximum of five years. The original power of attorney and any certificate of registration should be sent to the company at the above address or by e-mail to the above e-mail address in good time before the meeting. A proxy form is available on the company's website, www.sprintbioscience.se, and will also be sent to shareholders who so request and who provide their postal address.

Nominee-registered shares

Shareholders whose shares are registered in the name of a nominee through a bank or securities institution must, in order to be entitled to participate in the meeting, temporarily re-register the shares in their own name. Such registration must be completed at Euroclear Sweden AB on Wednesday 31 January 2018, which means that the shareholder must inform the nominee well in advance of this date.

Number of shares and votes

As of the date of this notice, there are a total of 7,574,836 shares in the company, which entitle the holder to one (1) vote per share at the meeting. Consequently, there are a total of 7,574,836 shares and 7,574,836 votes in the company.

Shareholders are reminded of their right to request information in accordance with Chapter 7, Section 32 and Section 57 of the Companies Act.

Proposal for the agenda

Opening of the General Meeting
Election of the Chairman of the General Meeting
Establishment and approval of the voting list
Approval of the agenda
Election of one or two persons to verify the minutes
Examination of whether the meeting has been duly convened
Resolution on new issue of shares and warrants (Units) with preferential rights for existing shareholders
Closure of the meeting

Proposal for a decision

Item 7 - Resolution on new issue of shares and warrants (Units) with preferential rights for existing shareholders

The Board of Directors proposes that the Annual General Meeting resolves to increase the company's share capital by a maximum of SEK 252,494.50 by issuing a maximum of 2,524,945 new shares.

The board of directors further proposes that the general meeting resolves to issue a maximum of 5,049,890 warrants of series 2018/2019:1 entitling to subscription of a total of 1,683,296 shares in the company, whereby the share capital may increase by a maximum of SEK 168,329.60 through the exercise of the issued warrants of series 2018/2019:1.

The issuances shall be treated as a decision and implemented in the form of issuance of so-called Units ("emissions").

The issue shall be made with preferential rights for existing shareholders on the following terms.

The right to subscribe for Units in the Issue shall, with preferential rights, be granted to those who are registered as shareholders in the company on the record date for the Issue. Each shareholder has preferential rights to subscribe for Units in proportion to the number of shares previously held by the shareholder.

One (1) existing share entitles to one (1) Unit right. Three (3) Unit Rights entitle to subscription of one (1) Unit consisting of one (1) new share and two (2) warrants of series 2018/2019:1. Three (3) warrants of series 2018/2019:1 entitle to subscription of one (1) share in the company.

The subscription price per Unit is SEK 15, corresponding to a subscription price of SEK 15 per share. The warrants are issued without consideration.

In the event that not all Units are subscribed for by virtue of Unit Rights, i.e. preferential rights, the Board of Directors shall, within the framework of the maximum amount of the Issue, decide on the distribution of Units not subscribed for with preferential rights. Such distribution shall primarily be made to subscribers who have subscribed for Units with the support of Unit Rights and, in the event of oversubscription, in proportion to the number of Unit Rights that each has utilised for subscription of Units and, to the extent that this cannot be done, by drawing lots. Secondly, distribution shall be made to shareholders and others who have expressed an interest in subscribing for Units without the support of Unit Rights and, in the event of oversubscription, in proportion to the amount subscribed, and to the extent that this cannot be done, by drawing lots. Thirdly, distribution shall be made to guarantors of the Issue pro rata in relation to the guaranteed amount.

The record date for determining which shareholders are entitled to subscribe for Units with preferential rights shall be Tuesday 13 February 2018.

Subscription of Units by virtue of Unit Rights shall be made by cash payment during the period from 15 February 2018 up to and including 1 March 2018. The Board of Directors shall be entitled to extend the time for subscription and payment. Subscription of Units without the support of Unit Rights shall be made during the time stated above. In such cases, subscription shall be made on a separate subscription list. Payment for Units subscribed for without preferential rights shall be made in cash no later than three (3) banking days after the dispatch of the settlement note showing the notice of allocation of Units. The Board of Directors shall be entitled to extend the time for subscription and payment. Subscription in respect of any subscription by an underwriter shall be made on a separate subscription list no later than five (5) banking days after the end of the subscription period. Payment for Units thus subscribed and allotted shall be made in cash no later than three (3) banking days after the dispatch of the settlement note showing the notice of allotment of Units. The Board of Directors shall be entitled to extend the time for subscription and payment.

The new shares shall entitle to dividends for the first time on the record date for dividends that occurs immediately after the Issue has been registered with the Swedish Companies Registration Office and the shares have been entered in the share register of Euroclear Sweden AB. The new shares issued following subscription by virtue of warrants of series 2018/2019:1 shall entitle to dividends for the first time on the record date for dividends that occurs immediately after the new shares have been registered with the Swedish Companies Registration Office and the shares have been entered in the share register maintained by Euroclear Sweden AB.

Three (3) warrants of series 2018/2019:1 entitle the holder to subscribe for one (1) new share in the company and the subscription price per share shall correspond to 70 per cent of the volume weighted average price of the company's share on Nasdaq First North Premier during the period from and including 14 January 2019 up to and including 25 January 2019, however not less than SEK 15 and not more than SEK 29. Subscription for shares in the company by virtue of warrants of series 2018/2019:1 may take place during the period from 28 January 2019 up to and including 8 February 2019.

The CEO, or the person appointed by the Board of Directors, shall be authorised to make any minor adjustments that may be required in connection with the registration of the resolution with the Swedish Companies Registration Office and Euroclear Sweden AB.

Other

The Board of Directors' complete proposals for resolutions in accordance with the above and other documents in accordance with the Swedish Companies Act will be available at the company's address Novum, Hälsovägen 7, SE-141 57 Huddinge, Sweden, and at www.sprintbioscience.se no later than two weeks prior to the Annual General Meeting and will be sent to shareholders who so request and who inform the company of their postal address.

Stockholm, January 2018

Sprint Bioscience AB (publ)

The Board of Directors